Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

Recruiting now

Conditions studied: Breast Carcinoma

In brief

The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.

Key facts

Study ID

NCT07207564

Run by

Mayo Clinic

People needed

4500

Starts

2025-08-28

Expected to finish

2030-06-30

Last updated by the study team

2026-03-13

Who can join

Age: 18 and older, up to 100. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female patients, ages 18 to 100 years
• Had a benign breast biopsy at Mayo Clinic between 2002-2022

You may not qualify if…

• All male patients
• Prior or concomitant diagnosis of BC
• Diagnosis of BC within six months of benign breast disease
• Denial of research authorization
• Concurrent or post-biopsy bilateral prophylactic mastectomy

Where it is running

• Mayo Clinic in Florida — Jacksonville, Florida, United States (enrolling)
• Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.